Roche Holding AG RHHVF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.22B | 19.37B | 19.13B | 19.11B | 18.76B |
| Total Other Revenue | 688.53M | 694.03M | 585.18M | 584.41M | 548.56M |
| Total Revenue | 19.90B | 20.06B | 19.72B | 19.69B | 19.30B |
| Cost of Revenue | 4.97B | 5.01B | 5.27B | 5.26B | 4.70B |
| Gross Profit | 14.94B | 15.05B | 14.45B | 14.43B | 14.61B |
| SG&A Expenses | 4.07B | 4.11B | 4.49B | 4.49B | 3.99B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -125.30M | -126.30M | 97.01M | 96.88M | -124.86M |
| Total Operating Expenses | 12.70B | 12.80B | 13.81B | 13.79B | 12.34B |
| Operating Income | 7.21B | 7.26B | 5.91B | 5.91B | 6.97B |
| Income Before Tax | 5.68B | 5.72B | 4.62B | 4.62B | 5.81B |
| Income Tax Expenses | 1.04B | 1.05B | 887.46M | 886.31M | 1.06B |
| Earnings from Continuing Operations | 4.64B | 4.67B | 3.73B | 3.73B | 4.75B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -287.31M | -289.60M | -311.05M | -310.65M | -255.79M |
| Net Income | 4.35B | 4.38B | 3.42B | 3.42B | 4.49B |
| EBIT | 7.21B | 7.26B | 5.91B | 5.91B | 6.97B |
| EBITDA | 8.20B | 8.26B | 6.88B | 6.87B | 7.90B |
| EPS Basic | 5.46 | 5.51 | 4.30 | 4.30 | 5.64 |
| Normalized Basic EPS | 4.98 | 5.02 | 3.91 | 3.90 | 4.89 |
| EPS Diluted | 5.39 | 5.43 | 4.26 | 4.26 | 5.59 |
| Normalized Diluted EPS | 4.91 | 4.95 | 3.87 | 3.87 | 4.85 |
| Average Basic Shares Outstanding | 796.00M | 796.00M | 796.00M | 796.00M | 796.00M |
| Average Diluted Shares Outstanding | 807.00M | 807.00M | 803.00M | 803.00M | 803.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 113.55% | 113.55% | 0.00% | 0.00% | 104.33% |